T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 12.8% |
| 4 | Industrials | 12.27% |
| 5 | Technology | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AOL
1751
DELISTED
AOL INC COMMON STOCK
AOL
| $877K | ﹤0.01% |
22,032
+66
| +0.3% | +$2.6K |
|
|
ISIL
1752
DELISTED
Intersil Corp
ISIL
| $875K | ﹤0.01% |
58,512
-8,200
| -12% | -$112K |
|
1753
Leidos
LDOS
$17.9B
| $870K | ﹤0.01% |
22,700
+1,900
| +9% | +$71.9K |
|
|
BRS
1754
DELISTED
Bristow Group, Inc.
BRS
| $869K | ﹤0.01% |
10,780
| – | – |
|
|
ODP
1755
DELISTED
ODP
ODP
| $867K | ﹤0.01% |
15,242
-1,635
| -10% | -$79.7K |
|
1756
Wendy's
WEN
$1.63B
| $863K | ﹤0.01% |
101,215
| – | – |
|
1757
Gentherm
THRM
$1.34B
| $862K | ﹤0.01% |
19,400
| – | – |
|
|
CPWR
1758
DELISTED
COMPUWARE CORP
CPWR
| $862K | ﹤0.01% |
89,838
| – | – |
|
1759
Sensient Technologies
SXT
$5.61B
| $857K | ﹤0.01% |
15,380
+1,300
| +9% | +$70.6K |
|
1760
Tetra Tech
TTEK
$9.32B
| $852K | ﹤0.01% |
154,875
+35,000
| +29% | +$192K |
|
|
CSR
1761
Centerspace
CSR
$941M
| $851K | ﹤0.01% |
9,239
+175
| +2% | +$15.5K |
|
1762
Webster Financial
WBS
$12.8B
| $849K | ﹤0.01% |
26,913
-5,700
| -17% | -$174K |
|
1763
Hanover Insurance
THG
$7.79B
| $847K | ﹤0.01% |
13,420
+1,200
| +10% | +$72.9K |
|
|
SJI
1764
DELISTED
South Jersey Industries, Inc.
SJI
| $835K | ﹤0.01% |
27,640
+3,600
| +15% | +$103K |
|
1765
Forward Air
FWRD
$637M
| $825K | ﹤0.01% |
17,235
+2,400
| +16% | +$108K |
|
|
ENH
1766
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $825K | ﹤0.01% |
16,000
-2,200
| -12% | -$114K |
|
|
TQNT
1767
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
| $822K | ﹤0.01% |
51,990
| – | – |
|
1768
MillerKnoll
MLKN
$1.61B
| $821K | ﹤0.01% |
27,150
-3,700
| -12% | -$115K |
|
|
RKUS
1769
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $820K | ﹤0.01% |
68,844
-16,653
| -19% | -$177K |
|
1770
Associated Banc-Corp
ASB
$6.09B
| $818K | ﹤0.01% |
45,242
| – | – |
|
1771
Boyd Gaming
BYD
$6.1B
| $813K | ﹤0.01% |
67,000
-20,100
| -23% | -$233K |
|
|
VRE
1772
DELISTED
Veris Residential
VRE
| $798K | ﹤0.01% |
37,134
+6,600
| +22% | +$139K |
|
|
APOL
1773
DELISTED
Apollo Education Group Inc Class A
APOL
| $798K | ﹤0.01% |
25,530
+3,030
| +13% | +$87.2K |
|
|
PFC
1774
DELISTED
Premier Financial Corp. Common Stock
PFC
| $797K | ﹤0.01% |
55,544
| – | – |
|
1775
MasTec
MTZ
$23.8B
| $795K | ﹤0.01% |
25,800
-3,500
| -12% | -$132K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.